Flavobacteriaceae bacteremia in children: A multicenter study

Keyphrases

• Bacteremia 100%
• Flavobacteriaceae 100%
• Young Age 33%
• Malignancy 33%
• Ciprofloxacin 33%
• Trimethoprim-sulfamethoxazole (TMP-SMX) 33%
• Piperacillin-tazobactam 33%
• Healthcare-associated 33%
• Central Line-associated Bloodstream Infection (CLABSI) 33%
• Israeli 16%
• Inherent Resistance 16%
• Antibiotics 16%
• Neonatal Period 16%
• Aging Period 16%
• Pediatric 16%
• Clinical Presentation 16%
• Neonate 16%
• Positive Blood Culture 16%
• High Mortality Rate 16%
• All-cause Mortality 16%
• Empirical Therapy 16%
• Aerobic 16%
• Multicenter Retrospective Study 16%
• Antibiotic Combination 16%
• Pathogenic Species 16%
• Resistance Pattern 16%
• Chryseobacterium Indologenes 16%
• Elizabethkingia Meningoseptica 16%
• Gram-negative Bacterial Infections 16%
• Rare Disease Diagnosis 16%
• One Percent 16%
• Rare Pathogen 16%

Medicine and Dentistry

• Bacteremia 100%
• Flavobacteriaceae 100%
• Antibiotics 33%
• Cancer 33%
• Pathogen 33%
• Piperacillin/Tazobactam 33%
• Ciprofloxacin 33%
• Trimethoprim/Sulfamethoxazole 33%
• Catheter Infection 33%
• Retrospective Study 16%
• Pediatrics 16%
• Neonate 16%
• Blood Culture 16%
• Mortality Rate 16%
• All Cause Mortality 16%
• Gram-Negative Bacterial Infection 16%
• Elizabethkingia Meningoseptica 16%
• Chryseobacterium indologenes 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Flavobacteriaceae 100%
• Bacteremia 100%
• Infectious Agent 33%
• Antibiotic Agent 33%
• Cotrimoxazole 33%
• Piperacillin Plus Tazobactam 33%
• Catheter Infection 33%
• Ciprofloxacin 33%
• Retrospective Study 16%
• Mortality Rate 16%
• All Cause Mortality 16%
• Gram Negative Infection 16%
• Chryseobacterium indologenes 16%
• Elizabethkingia Meningoseptica 16%